China launched a pilot project to improve its rare disease healthcare levels.
China is facing the great challenge of serving the world's largest rare disease population. It is necessary to develop a specific medical plan to increase the levels of optimal prevention, diagnosis and treatment of rare diseases under the existing clinical service structures in China. In 2013, China launched its first pilot project focused on 20 representative rare diseases. A national network including approximately 100 provincial or municipal medical centers has been established to enable collaboration on rare diseases across China. The main objectives for this project are to develop and apply medical guidelines and clinical pathways for rare diseases, to establish a rare disease patient registry and data repository system, and to promote molecular testing for rare genetic disorders. This project also emphasizes building close links among the collaborative network, clinicians on the frontlines in basic medical services institutions and rare disease patient organizations. Primarily, this project expects to develop an actionable medical services plan to increase the delivery of quality healthcare for individuals and families living with rare diseases in China within five years.
Yazhou
Y
Cui
Xiaoyan
X
Zhou
Shandong Academy of Medical Science, Shandong Medical Biotechnological Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Jinan 250062, China. samshjx@sina.com.
Jinxiang
J
Han
D002681:China; D003299:Cooperative Behavior; D006801:Humans; D010865:Pilot Projects; D017410:Practice Guidelines as Topic; D011787:Quality of Health Care; D035583:Rare Diseases / Q000628:therapy*